Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Antimicrobial Susceptibility Testing Market

Veterinary Antimicrobial Susceptibility Testing Market Size, Industry Outlook Report, Regional Analysis, Application Development, Price Trends, Competitive Market Share & Forecast, 2024 – 2032

  • Report ID: GMI5535

Veterinary Antimicrobial Susceptibility Testing Market Size

Veterinary Antimicrobial Susceptibility Testing Market size is projected to exhibit substantial growth between 2024 and 2032, owing to the rising threats of antimicrobial resistance. The growing demand for animal-derived products, rising need for pet insurance and higher healthcare spending is driving the increasing government initiatives to tackle antimicrobial resistance.

The expanding livestock population and the growing demand for healthy and high-quality livestock products is driving the need for antimicrobial susceptibility testing (AST). According to the Agriculture and Horticulture Development Board, there were 20.1 million dairy cows in the EU in 2022. The well-established awareness campaigns for animal diseases and treatment are increasing the appeal of antimicrobial testing techniques. The influx of supportive government initiatives, technological advancements, and the rapid surge in research collaborations will further complement the industry growth. However, limited awareness among veterinarians, regulatory challenges, and the rising concerns regarding antimicrobial resistance may negatively influence the demand for AST in the forecast period.

Veterinary Antimicrobial Susceptibility Testing Market Trends

The increasing adoption of rapid diagnostic techniques, such as molecular methods and automated systems are facilitating quicker and more accurate testing results. The growing emphasis on implementing antimicrobial stewardship programs in veterinary practices is encouraging responsible antimicrobial use. The integration of data analytics and artificial intelligence (AI) into testing platforms is enabling better interpretation of susceptibility data and guiding treatment decisions. The rise of multiplex testing platforms to detect multiple antimicrobial resistances simultaneously is also gaining traction, further offering enhanced efficiency and cost-effectiveness.

Veterinary Antimicrobial Susceptibility Testing Market Analysis

Based on product, the market value from the automated AST instruments segment is estimated to increase at commendable pace through 2032, owing to the increasing demand for rapid and accurate testing results. Automation streamlines testing processes and reduces turnaround time and labor costs for veterinary practices. The integration of advanced technologies, such as AI enhances data analysis and interpretation, further boosting the efficiency and reliability of automated AST instruments. With innovative computer software, the equipment helps interpret susceptibility patterns for each organism and produces error-free findings.

In terms of animal type, the livestock segment is estimated to accumulate significant revenue share of the veterinary antimicrobial susceptibility testing industry by 2032. This can be ascribed to the rising global demand for livestock antibiotics and other products. According to the National Library of Medicine, the global antimicrobial sales are anticipated to rise by 11.5% in 2030 to 104,079 tonnes. This increasing sales of microbials and their overuse are fueling the demand for susceptibility testing. The rising concerns about food safety and antimicrobial resistance are also encouraging livestock producers to prioritize regular susceptibility testing. Significant advancements in testing technologies, such as rapid diagnostic methods are further enhancing the efficiency and accuracy of antimicrobial susceptibility testing in livestock.

North America veterinary antimicrobial susceptibility testing market size is anticipated to expand at notable rate between 2024 and 2032, due to the increasing prevalence of antimicrobial-resistant infections in animals. The rollout of stringent regulations is promoting responsible antimicrobial use and increasing the awareness among veterinarians and animal owners about the importance of susceptibility testing. The rapid developments in testing technologies and strong presence of established veterinary diagnostics companies will also contribute to the regional industry expansion.

Veterinary Antimicrobial Susceptibility Testing Market Share

Companies operating in the veterinary antimicrobial susceptibility testing industry are adopting various corporate strategies, such as mergers & acquisitions and partnerships to come up with new innovative solutions and expand their consumer base.

Some of the major veterinary antimicrobial susceptibility testing companies are:

  • BioMérieux SA
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Danaher Corporation
  • Becton Dickinson & Company
  • Synbiosis
  • Liofilchem S.r.l.
  • HiMedia Laboratories
  • Bio-Rad Laboratories
  • Neogen Corporation
  • Mast Group Ltd.
  • Condalab
  • FASTinov
  • Hardy Diagnostics
  • Bioguard Corporation
  • SSI Diagnostica A/S

Veterinary Antimicrobial Susceptibility Testing Industry News:

  • In August 2022, Becton, Dickinson, and Company partnered with Accelerate Diagnostics to globally distribute Accelerate's rapid antibiotic resistance and susceptibility testing solution with the aim to provide results within hours.

What Information does this report contain?

Historical data coverage: 2018 to 2023; Growth Projections: 2024 to 2032.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The veterinary antimicrobial susceptibility testing industry size was worth USD 100 million in 2022 and is anticipated to expand at a CAGR of 5-7% from 2023 to 2032.

Automated AST instruments is projected to rise significantly over 2032 on account of product benefits such as shorter turnaround & identification time.

North America veterinary AST market size is poised to amass sizeable revenue growth by 2032 owing to the increasing prevalence of antibiotic-resistant infections in the region.

BioMérieux SA, Becton, Synbiosis, Liofilchem S.r.l., Neogen Corporation, Condalab, FASTinov, Hardy Diagnostics, Bioguard Corporation, and SSI Diagnostica A/S are some of the key companies in the market.

Pre Book Now